|Home > About Us > Faculty Directory > Youngman Oh, PhD
Youngman Oh, PhD
Professor of Pathology and Biochemistry
Director of Cancer and Metabolic Syndrome Lab
Department of Pathology
Virginia Commonwealth University Health System
Education | VCU/MCV Appointments | Professional Organizations |
Professional Service | Editorial Advisory Boards | Recent Grants |
Recent Invited Presentations | Recent Publications
PhD, Cancer Biology
Stanford, CA 1989-1993
Eastern Michigan University
Ypsilanti, MI 1985-1987
Summa cum Laude
Korea University, Seoul 1977-1984
Virginia Commonwealth University and Medical Center Appointments
Member, Virginia Bio-Technology Research Park’s Leadership Council, Virginia Commonwealth University. 2008-present
Professor, Integrative Life Sciences Program, Virginia Commonwealth
Director of Cancer and Metabolic Syndrome Lab, Dept. of Pathology, MCV Campus, Virginia Commonwealth University. 2010-present
Professor, Dept. of Biochemistry, MCV Campus, Virginia Commonwealth University. 2003-present
Member Scientist, Massey Cancer Center, Virginia Commonwealth University. 2003-present
Professor, Dept. of Pathology, Medical College of Virginia Campus, Virginia Commonwealth University. 2003-present
The Endocrine Society
American Association for Cancer Research
American Association for the Advancement of Science
The Western Society for Pediatric Research
Back to top
Ad hoc reviewer and Chair of the IGFs and IGFBPs in Aging and Disease section for the Fifth International Congress of the GRS and the IGF Society, 2010.
Ad hoc reviewer and Chair of the IGF and Physiology section for the Fourth International Congress of the GRS and the IGF Society, 2008.
External Examiner Committee member of the Ph.D. thesis for National University of Singapore, 2004, 2005.
Study section member for the Congressionally Directed Medical Research Program (CDMRP) Prostate Cancer Research Program (PCRP) Peer Review panel, 2006, 2007, 2011.
Ad hoc reviewer and Scientific Advisor of the Hormone and Cancer Section for the 87th Annual Meeting of The Endocrine Society, 2005.
Scientific Reviewer on the Jeffress Memorial Trust Funds, 2010
Oregon State Medical Research Foundation Committee, 1999-2003.
Oregon Health Sciences University Research Radiation Safety Committee, 1999-2003.
Editorial Advisory Boards
American Journal of Physiology-Endocrinology and Metabolism, 2010-present
Impact of MicroRNA-200 Family on Epithilial-to-Mesenchymal Transition, Invasion and Sensitivity to Radiotherapy in Prostate Cancer. (Massey Cancer Center) (PI), 2010-2011
Molecular mechanisms of IGFBP-3 regulation on GFP78-induced anti-estrogen resistance in breast cancer (U.S. Army Breast Cancer Career Development Award) (PI), 2009-2013
Novel NF-kB inhibitory action of IGFBP-3 in prostate cancer: New paradigm for suppression of angiogenesis and chemoresistance (U.S. Army Prostate Cancer Research Idea Development Award) (PI), 2007-2011
Role of CTGF/IGFBP-8 for radiation-induced fibrosis. (Massey Cancer Center) (PI), 2007-2008
Dysregulation of the IGFBP-3/IGFBP-3 receptor axis in prostate tumorigenesis (U.S. Army Prostate Cancer Research Idea Development Award) (PI), 2004-2008
IGFBP-3 Receptor: a New Class of Cell-death Receptor in Breast Cancer (U.S. Army Breast Cancer Research Idea Award) (PI), 2003-2007
Back to top
Recent Invited Presentations
Invited speaker, The 84th Annual Meeting of The Endocrine Society, San Francisco, California, June 2002.
Invited speaker, International Symposium on the Functional Role of Insulin-like Growth Factor-Binding Proteins, Tuebingen, Germany, Nov. 2002.
Invited speaker, Pharmacia Distingushed Scientist Speaker Program, Tokyo, Japan, Nov, 2003.
Invited speaker, 9th World Congress on Advances in Oncology and 7th International Symposium on Molecular Medicine, Crete, Greece, Oct. 2004.
Invited speaker, International Biomedical Science Conference, Yunnan, China, Dec. 2004.
Invited speaker, The 87th Annual Meeting of The Endocrine Society, San Diego, California, June 2005.
Invited speaker, The “Era of Hope”, Department of Defense Breast Cancer Research Program Meeting, Philadelphia, Pennsylvania, June 2005.
Invited speaker, “Role of IGF system in human cancer, aging and inflammatory diseases”, Grand Rounds, State Key Laboratory of Molecular Oncology, Beijing, China, Nov. 2006.
Invited speaker, “Novel NF-κB Inhibitory Action of IGFBP-3 in Human Cancer: New Paradigm for Suppression of Angiogenesis, Metastasis and Chemo/Radio-resistance in Human Cancer Cells”, The 3rd International Congress of the GRS and the IGF Society Meeting, Kobe, Japan Nov. 2006.
Invited speaker, “A Novel Target for Asthma, COPD and Arthritis”, The 4th International Congress of the GRS and the IGF Society Meeting, Genoa, Italy, Sept. 2008.
Invited speaker, “Recent Advances in Control of Fibrotic Disorders”, The 10th Korean Society of Pediatric Nephrology Meeting (KSPN) Busan, Korea, July 2009.
Invited speaker, “New Insights on Metabolic Syndrome”, The 10th Korean Society of Pediatric Nephrology Meeting (KSPN) Busan, Korea, July 2009.
Invited speaker, “Trends of Antibody Therapy for Human Disease”, The 10th Korean Society of Pediatric Nephrology Meeting (KSPN) Busan, Korea, July 2009.
Invited speaker, “New paradigm for antitumor action of IGF binding protein-3 in prostate cancer”, 14th World Congress on Advances in Oncology and 12th International Symposium on Molecular Medicine, Loutraki, Greece, Oct. 2009.
Invited speaker, “Therapeutic potential of IGFBP-3 for cancer and inflammatory disease: IGF-independent cross-talk and interference with NF-kB signaling” International Anatomical Sciences and Cell Biology Conference, Singapore, May, 2010.
Invited speaker, “Therapeutic potential of IGFBP-3 for cancer and metabolic syndrome”, The Korean Society of Gynecologic Endocrinology Symposium, Seoul, Korea, July. 2010.
Back to top
Recent Publications (from 98 publications)
Peer Reviewed Publications:
Jogie-Brahim S; Min H-K; Oh Y. Proteomic approach for investigation of IGF-independent actions of IGFBPs in cancer, Expert Rev. Proteomics, 2005, 2:71-86.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y. Insulin-like Growth Factor Binding Protein-3 Induces G1 Cell Cycle Arrest with Inhibition of Cyclin-dependent Kinase 2 and 4 in MCF-7 Human Breast Cancer Cells. Horm Metab Res. 2010, 42(3):165-172.
Ingermann AR; Yang YF; Han J; Mikami A; Garza AE; Mohanraj L; Fan L; Idowu M; Ware JL; Kim HS Lee DY; Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced antitumor effects in breast and prostate cancer. J. Biol. Chem, 2010, 230(39): 30233-30246.
Mohanraj L; Oh Y. Targeting the IGF system in cancer: The current and future In breast cancer therapy. Recent Pat Anticancer Drug Discov. 2011, 6: 166-177.
Lee YC, Jogie-Brahim S, Lee DY; Han J; Harada A; Murphy LJ; Oh Y. IGFBP-3 blocks the effects of asthma by negatively regulating NF-kB signaling through IGFBP-3R-mediated activation of caspases J. Biol. Chem, 2011, 286(20):17898-17909
Han J; Jogie-Brahim S; Harada A; Oh Y. IGF binding protein-3 suppresses tumor growth through inhibition of tumor-induced NF-κB activity. Cancer Letter, 2011, 307: 200-210.
Yoo EG; Lee WJ; Kim JH; Chae HW; Hyun SE; Kim DH; Kim HS; Oh Y. Insulin-like growth factor binding protein-3 mediates high glucose-induced apoptosis by increasing oxidative stress in porcine proximal tubular epithelial cells. Endocrinology, 2011, 6: 166-177.
Mohanraj L; Oh Y., Impact of IGF System on Dietary Short Chain Fatty Acid-Induced Anti-Inflammatory and Anti-Tumor Effects, Biomedical Research, 2012, in press
Oh Y. The Insulin-like growth factor (IGF) system in chronic kidney disease: Pathophysiology and therapeutic opportunities. Kidney Research and Clinical Practice, 2012, in press
Werner H; Oh Y; Roberts CT Jr. Apoptosis in breast cancer. In “Programmed Cell Death Volume II: Role in Disease, athogenesis and Prevention” Mattson MP, Estus S, Rangnekar V, eds, “Advances in Cell Aging and Gerontology “ Elsevier Science, Netherlands, 2001, vol. 6:1-22.
Walker GE; Kim H-S; Yang Y-F; Oh Y. IGF-independent effects of the IGFBP Superfamily. In “Insulin-like Growth Factor” Le Roith D, Zumkeller W, Baxter R, eds, Landes Bioscience, 2003.
Minniti G; Oh Y. Insulin-like growth factor binding proteins in endocrine-related neoplasia. In “Endocrine Oncology’ Ethier SP, ed, “Contemporary Endocrinology" Humana Press, NJ 2000, vol. 17:215-236.
Back to top